202 related articles for article (PubMed ID: 8404380)
21. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study.
Ribaldone DG; Imperatore N; Le Grazie M; Furfaro F; Balestrieri P; De Blasio F; Fagoonee S; Mosso E; Boano V; Reggio D; Sarli E; Castiglione F; Milla M; Vecchi M; Saracco GM; Salizzoni M; Romagnoli R; Fiorino G; Astegiano M;
Dig Liver Dis; 2021 Jun; 53(6):712-716. PubMed ID: 32972831
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
23. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
Papatheodoridis GV; Hamilton M; Mistry PK; Davidson B; Rolles K; Burroughs AK
Gut; 1998 Nov; 43(5):639-44. PubMed ID: 9824344
[TBL] [Abstract][Full Text] [Related]
24. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
25. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.
Liu K; Strasser SI; Koorey DJ; Leong RW; Solomon M; McCaughan GW
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):949-960. PubMed ID: 28627935
[TBL] [Abstract][Full Text] [Related]
26. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
Åberg F; Abdulle A; Mäkelä A; Nissinen M
Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
[TBL] [Abstract][Full Text] [Related]
27. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.
Jørgensen KK; Grzyb K; Lundin KE; Clausen OP; Aamodt G; Schrumpf E; Vatn MH; Boberg KM
Inflamm Bowel Dis; 2012 Mar; 18(3):536-45. PubMed ID: 21456044
[TBL] [Abstract][Full Text] [Related]
30. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
[TBL] [Abstract][Full Text] [Related]
31. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
32. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
33. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
Lian L; Menon KV; Shen B; Remzi F; Kiran RP
Dis Colon Rectum; 2012 Jan; 55(1):79-84. PubMed ID: 22156871
[TBL] [Abstract][Full Text] [Related]
36. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
Poritz LS; Koltun WA
Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890
[TBL] [Abstract][Full Text] [Related]
37. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.
Lee DU; Menegas S; Lee KJ; Pu A; Bhowmick K; Ponder R; Fan GH; Chou H; Lee K; Urrunaga NH
Dig Dis Sci; 2023 Sep; 68(9):3781-3800. PubMed ID: 37450231
[TBL] [Abstract][Full Text] [Related]
38. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory bowel disease in liver transplanted patients.
Filipec Kanizaj T; Mijic M
World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
